SCHEMBL24032604

SCHEMBL24032604

CC(C)(C)c1ccc(C(C)(O)CO)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.50
TYR P14679 1/20 0.50
TSHR P16473 1/20 0.46
HDAC1 Q13547 1/20 0.40
PDK1 Q15118 1/20 0.40
PDK2 Q15119 1/20 0.40
PDK3 Q15120 1/20 0.40
PDK4 Q16654 1/20 0.40
SLC22A2 O15244 1/20 0.40
SLC22A1 O15245 1/20 0.40
SLC22A3 O75751 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MAPT P10636 1/20 0.39
BCHE P06276 3/20 0.39
ACHE P22303 3/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16174369 0.83 TSHR (0.50) LMNATSHRNPC1RAB9AMAPT
SCHEMBL14934282 0.83 TSHR (0.50) LMNATSHRNPC1RAB9AMAPT
SCHEMBL12765048 0.83 TSHR (0.50) LMNATSHRNPC1RAB9AMAPT
SCHEMBL7427753 0.83 ESR2 (0.54) LMNATYRTSHRALDH1A1HPGD
SCHEMBL6480252 0.81 KMT2A (0.60) TSHRSMN1; SMN2
SCHEMBL18545312 0.81 APP (0.39) LMNATYRSMN1; SMN2HSD17B10TNKS
SCHEMBL5698989 0.81 KIF11 (0.41) LMNATSHRALDH1A1KIF11
SCHEMBL10400441 0.81 MAPT (0.42) NPC1RAB9AMAPTACHEALDH1A1
SCHEMBL5698993 0.81 KIF11 (0.41) LMNATSHRALDH1A1KIF11
SCHEMBL22928386 0.81 TNKS (0.37) TSHRNPC1RAB9AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210355110-A1 THYROID HORMONE RECEPTOR AGONISTS InventisBio Co., Ltd. (CN) 2021-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210355110-A1 THYROID HORMONE RECEPTOR AGONISTS TSHR, THRA, TRHR LMNA 3230/4885TYR 3614/4885TSHR 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.